Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
Simon J. Cleary, Simon C. Pitchford, Richard T. Amison, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4851-4865
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
Emma S. Winkler, Adam L. Bailey, Natasha M. Kafai, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1327-1335
Open Access | Times Cited: 904
The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos, Aaron Gupta, Jeffrey V. Ravetch
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 633-643
Open Access | Times Cited: 458
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Cheol-Min Kim, Dong-Kyun Ryu, Jihun Lee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 276
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 43, pp. 26955-26965
Open Access | Times Cited: 264
SARS-CoV-2 infection, disease and transmission in domestic cats
Natasha N. Gaudreault, Jessie D. Trujillo, Mariano Carossino, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2322-2332
Open Access | Times Cited: 259
Can Activation of NRF2 Be a Strategy against COVID-19?
Antonio Cuadrado, Marta Pajares, Cristina Benito, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 9, pp. 598-610
Open Access | Times Cited: 216
Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia
Marianna Zazhytska, Albana Kodra, Daisy A. Hoagland, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1052-1064.e12
Open Access | Times Cited: 210
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
Adam L. Bailey, Oleksandr Dmytrenko, Lina Greenberg, et al.
JACC Basic to Translational Science (2021) Vol. 6, Iss. 4, pp. 331-345
Open Access | Times Cited: 162
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin, Andrew Jones, Hans-Heinrich Hoffmann, et al.
Nature (2021) Vol. 599, Iss. 7885, pp. 465-470
Open Access | Times Cited: 162
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109400-109400
Open Access | Times Cited: 150
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
James P. Bridges, Eszter K. Vladar, Hua Huang, et al.
Thorax (2021) Vol. 77, Iss. 2, pp. 203-209
Open Access | Times Cited: 134
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Mariann Gyöngyösi, Pilar Alcaide, Folkert W. Asselbergs, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 336-356
Open Access | Times Cited: 122
Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins
Yajuan Rui, Jiaming Su, Si Shen, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 115
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
Per Johan Klasse, Douglas F. Nixon, John P. Moore
Science Advances (2021) Vol. 7, Iss. 12
Open Access | Times Cited: 110
The Importance of Animal Models in Biomedical Research: Current Insights and Applications
Adriana Domínguez-Oliva, Ismael Hernández-Ávalos, Julio Martı́nez-Burnes, et al.
Animals (2023) Vol. 13, Iss. 7, pp. 1223-1223
Open Access | Times Cited: 100
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Jonas Cerneckis, Hongxia Cai, Yanhong Shi
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals
Carlos A. Cañas
Medical Hypotheses (2020) Vol. 145, pp. 110345-110345
Open Access | Times Cited: 101
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection
Jakob Trimpert, Daria Vladimirova, Kristina Dietert, et al.
Cell Reports (2020) Vol. 33, Iss. 10, pp. 108488-108488
Open Access | Times Cited: 93
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
Recent progress in translational engineeredin vitromodels of the central nervous system
Polyxeni Nikolakopoulou, Rossana Rauti, Dimitrios Voulgaris, et al.
Brain (2020) Vol. 143, Iss. 11, pp. 3181-3213
Open Access | Times Cited: 86
Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters?
Achim D. Gruber, Nikolaus Osterrieder, Luca D. Bertzbach, et al.
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 63, Iss. 6, pp. 856-859
Open Access | Times Cited: 75
Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19
Hayate Javed, Mohamed Fizur Nagoor Meeran, Niraj Kumar Jha, et al.
Frontiers in Plant Science (2021) Vol. 11
Open Access | Times Cited: 74
The role of type I interferon in the treatment of COVID‐19
Fatemeh Sodeifian, Mahsa Nikfarjam, Naghmeh Kian, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 63-81
Open Access | Times Cited: 73
Hamster models of COVID-19 pneumonia reviewed: How human can they be?
Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, et al.
Veterinary Pathology (2021) Vol. 59, Iss. 4, pp. 528-545
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top